Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplastons A10 and AS2-1 in Glioblastoma Multiforme
NCT00003456Phase 2Completed
- Sponsor
- Burzynski Research Institute
- Start
- Mar 1995
- Primary completion
- Dec 2004
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in glioblastoma multiforme (GBM), sponsored by Burzynski Research Institute. Started Mar 1995; status: completed.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00003456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003456.